Axel Vater

2.7k total citations
39 papers, 1.8k citations indexed

About

Axel Vater is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Axel Vater has authored 39 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Immunology and 8 papers in Oncology. Recurrent topics in Axel Vater's work include Advanced biosensing and bioanalysis techniques (9 papers), Complement system in diseases (7 papers) and RNA Interference and Gene Delivery (6 papers). Axel Vater is often cited by papers focused on Advanced biosensing and bioanalysis techniques (9 papers), Complement system in diseases (7 papers) and RNA Interference and Gene Delivery (6 papers). Axel Vater collaborates with scholars based in Germany, United States and Switzerland. Axel Vater's co-authors include Sven Klußmann, Kai Hoehlig, Christian Maasch, Dirk Eulberg, Dirk Zboralski, Werner G. Purschke, Klaus Buchner, A. Scheed, Ralph T. Schermuly and Friedrich Grimminger and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Advanced Materials.

In The Last Decade

Axel Vater

37 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Axel Vater Germany	21	886	472	347	294	175	39	1.8k
Maike Frye Germany	18	809 0.9×	342 0.7×	148 0.4×	312 1.1×	94 0.5×	31	1.6k
Peter W. Hewett United Kingdom	24	988 1.1×	422 0.9×	141 0.4×	302 1.0×	78 0.4×	42	2.0k
Abigail Woodfin United Kingdom	19	919 1.0×	1.2k 2.6×	194 0.6×	233 0.8×	87 0.5×	24	2.6k
Gaoyuan Cao United States	24	907 1.0×	246 0.5×	331 1.0×	184 0.6×	88 0.5×	45	1.9k
Jianzhong Ai China	23	762 0.9×	192 0.4×	376 1.1×	416 1.4×	117 0.7×	125	1.9k
Michael J. Flister United States	22	758 0.9×	213 0.5×	161 0.5×	599 2.0×	152 0.9×	53	1.6k
Sarah Berndt Belgium	24	673 0.8×	519 1.1×	112 0.3×	177 0.6×	113 0.6×	55	1.9k
Lucie Poupel France	17	414 0.5×	630 1.3×	181 0.5×	290 1.0×	44 0.3×	30	1.4k
Rinat Zaynagetdinov United States	21	498 0.6×	783 1.7×	436 1.3×	396 1.3×	60 0.3×	33	1.8k
Marion Wiesnet Germany	13	981 1.1×	282 0.6×	112 0.3×	135 0.5×	73 0.4×	17	1.5k

Countries citing papers authored by Axel Vater

Since Specialization

Citations

This map shows the geographic impact of Axel Vater's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Axel Vater with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Axel Vater more than expected).

Fields of papers citing papers by Axel Vater

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Axel Vater. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Axel Vater. The network helps show where Axel Vater may publish in the future.

Co-authorship network of co-authors of Axel Vater

This figure shows the co-authorship network connecting the top 25 collaborators of Axel Vater. A scholar is included among the top collaborators of Axel Vater based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Axel Vater. Axel Vater is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hoehlig, Kai, et al.. (2025). AON-D21 – Complement C5a-neutralizing human/mouse cross-reactive L-aptamer from bench to phase 2 clinical trial. Immunobiology. 230(4). 153013–153013.

Kaiser, David A., Werner G. Purschke, Simone Sell, et al.. (2024). Ultrasensitive Detection of Chemokines in Clinical Samples with Graphene‐Based Field‐Effect Transistors. Advanced Materials. 36(52). e2407487–e2407487. 10 indexed citations

Kaiser, David A., Werner G. Purschke, Simone Sell, et al.. (2024). Ultrasensitive Detection of Chemokines in Clinical Samples with Graphene‐Based Field‐Effect Transistors (Adv. Mater. 52/2024). Advanced Materials. 36(52).

Müller-Redetzky, Holger, Sandra-Maria Wienhold, Birgitt Gutbier, et al.. (2020). Neutralizing Complement C5a Protects Mice with Pneumococcal Pulmonary Sepsis. Anesthesiology. 132(4). 795–807. 22 indexed citations

Khan, Mohammad Afzal, et al.. (2018). C5a Blockade Increases Regulatory T Cell Numbers and Protects Against Microvascular Loss and Epithelial Damage in Mouse Airway Allografts. Frontiers in Immunology. 9. 1010–1010. 15 indexed citations

Ajona, Daniel, Sergio Ortiz‐Espinosa, Haritz Moreno, et al.. (2017). A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis. Cancer Discovery. 7(7). 694–703. 187 indexed citations

Tanihata, Jun, et al.. (2017). Low-Intensity Training and the C5a Complement Antagonist NOX-D21 Rescue the mdx Phenotype through Modulation of Inflammation. American Journal Of Pathology. 187(5). 1147–1161. 21 indexed citations

Zboralski, Dirk, Anna Kruschinski, Dirk Eulberg, & Axel Vater. (2016). CXCL12 inhibition with NOX-A12 (olaptesed pegol) increases T and NK cell infiltration and synergizes with immune checkpoint blockade in tumour-stroma spheroids. Annals of Oncology. 27. vi371–vi371. 1 indexed citations

Enzmann, Volker, Stéphanie Lecaudé, Anna Kruschinski, & Axel Vater. (2016). CXCL12/SDF-1-Dependent Retinal Migration of Endogenous Bone Marrow-Derived Stem Cells Improves Visual Function after Pharmacologically Induced Retinal Degeneration. Stem Cell Reviews and Reports. 13(2). 278–286. 20 indexed citations

10.

Yatime, Laure, Christian Maasch, Kai Hoehlig, et al.. (2015). Structural basis for the targeting of complement anaphylatoxin C5a using a mixed L-RNA/L-DNA aptamer. Nature Communications. 6(1). 6481–6481. 70 indexed citations

11.

Brockmann, Claudia, Tobias Brockmann, Catharina Busch, et al.. (2015). Intravitreal inhibition of complement C5a reduces choroidal neovascularization in mice. Graefe s Archive for Clinical and Experimental Ophthalmology. 253(10). 1695–1704. 11 indexed citations

12.

Mavroidis, Manolis, Constantinos H. Davos, Stelios Psarras, et al.. (2015). Complement system modulation as a target for treatment of arrhythmogenic cardiomyopathy. Basic Research in Cardiology. 110(3). 27–27. 37 indexed citations

13.

Vater, Axel & Sven Klußmann. (2014). Turning mirror-image oligonucleotides into drugs: the evolution of Spiegelmer® therapeutics. Drug Discovery Today. 20(1). 147–155. 190 indexed citations

14.

Schneider, Gabriela, Ahmed Abdel‐Latif, Janina Ratajczak, et al.. (2013). Bioactive Lipids S1P and C1P Are Prometastatic Factors in Human Rhabdomyosarcoma, and Their Tissue Levels Increase in Response to Radio/Chemotherapy. Molecular Cancer Research. 11(7). 793–807. 61 indexed citations

15.

Vater, Axel, Nicolaus Kröger, Stefan Zöllner, et al.. (2013). Hematopoietic Stem and Progenitor Cell Mobilization in Mice and Humans by a First-in-Class Mirror-Image Oligonucleotide Inhibitor of CXCL12. Clinical Pharmacology & Therapeutics. 94(1). 150–157. 63 indexed citations

16.

Vater, Axel, Simone Sell, Przemysław Kaczmarek, et al.. (2013). A Mixed Mirror-image DNA/RNA Aptamer Inhibits Glucagon and Acutely Improves Glucose Tolerance in Models of Type 1 and Type 2 Diabetes. Journal of Biological Chemistry. 288(29). 21136–21147. 49 indexed citations

17.

Savai, Rajkumar, Soni Savai Pullamsetti, Ewa Bieniek, et al.. (2012). Immune and Inflammatory Cell Involvement in the Pathology of Idiopathic Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 186(9). 897–908. 308 indexed citations

18.

Darisipudi, Murthy N., Onkar P. Kulkarni, Sufyan G. Sayyed, et al.. (2011). Dual Blockade of the Homeostatic Chemokine CXCL12 and the Proinflammatory Chemokine CCL2 Has Additive Protective Effects on Diabetic Kidney Disease. American Journal Of Pathology. 179(1). 116–124. 94 indexed citations

19.

Maasch, Christian, Axel Vater, Klaus Buchner, et al.. (2010). Polyetheylenimine-Polyplexes of Spiegelmer NOX-A50 Directed against Intracellular High Mobility Group Protein A1 (HMGA1) Reduce Tumor Growth in Vivo. Journal of Biological Chemistry. 285(51). 40012–40018. 31 indexed citations

20.

Ji, Wan, Li Cai, Matthew B. Wright, et al.. (2000). Preservation of Gene Expression Ratios Among Multiple Complex cDNAs After PCR Amplification: Application to Differential Gene Expression Studies. Journal of Structural and Functional Genomics. 1(1). 1–7. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact